Holen Sie sich die Stockscreener-App
1.37
6.20%
0.08
Handel nachbörslich:
1.35
-0.02
-1.46%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.29
24-Stunden-Volumen:
1.80M
Relative Volume:
1.44
Marktkapitalisierung:
$390.14M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.4421
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+9.60%
1M Leistung:
+30.48%
6M Leistung:
-21.71%
1J Leistung:
-22.60%
1-Tages-Spanne:
$1.26
$1.39
1-Wochen-Bereich:
$1.15
$1.39
52-Wochen-Spanne:
$0.92
$2.41
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.37 | 390.14M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
With 48% stake, Standard BioTools Inc. (NASDAQ:LAB) seems to have captured institutional investors' interest - Yahoo
Deeper Dive: Understanding Standard BioTools Inc (LAB) Through its Various Ratios - DWinneX
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by Bank of America Corp DE - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by California State Teachers Retirement System - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $970,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Two Sigma Investments LP - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Stake Cut by Nuveen Asset Management LLC - Defense World
Standard BioTools: Too Early To Determine The Fate Of This Turnaround (NASDAQ:LAB) - Seeking Alpha
ProShare Advisors LLC Buys 27,334 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
BNP Paribas Financial Markets Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Insider Selling: Standard BioTools Inc. (NASDAQ:LAB) SVP Sells 13,217 Shares of Stock - MarketBeat
Jane Street Group LLC Has $414,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webc - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | L - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | LAB Stock News - GuruFocus
Deutsche Bank AG Increases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural 'Proteomics Roundtable” Webcast Series - The Manila Times
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series - GlobeNewswire
Standard BioTools to host inaugural ‘Proteomics Roundtable’ series - TipRanks
Top Executive Sells Thousands of Standard BioTools Shares! - TipRanks
Standard biotools CEO Michael Egholm sells $5,150 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,150 in stock - Investing.com
Standard biotools CEO Michael Egholm sells $5,126 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,126 in stock - Investing.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 79% - simplywall.st
Standard BioTools Inc. (NASDAQ:LAB) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Standard biotools executive sells $25,784 in stock By Investing.com - Investing.com South Africa
Standard biotools executive sells $25,784 in stock - Investing.com India
Standard Biotools CEO Michael Egholm sells shares worth $4,860 - Investing.com Australia
Standard Biotools CEO Michael Egholm sells shares worth $4,860 By Investing.com - Investing.com India
Fluidigm stock plunges to 52-week low of $0.95 - Investing.com Australia
Fluidigm stock plunges to 52-week low of $0.95 By Investing.com - Investing.com Canada
Northern Trust Corp Has $5.03 Million Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Dimensional Fund Advisors LP - Defense World
Price T Rowe Associates Inc. MD Buys 16,475 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference - MarketScreener
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships - MSN
Before You Sell Standard BioTools Inc (NASDAQ: LAB) Shares, Here’sWhat You Need To Know. - Stocksregister
Standard BioTools First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Purchases 40,057 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. Earnings Call: Mixed Outlook Amid Challenges - TipRanks
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Standard Biotools Inc-Aktie (LAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mackay Sean | SVP & Chief Business Officer |
May 23 '25 |
Sale |
0.94 |
13,217 |
12,437 |
843,076 |
| Egholm Michael | President & CEO |
May 23 '25 |
Sale |
0.94 |
5,473 |
5,150 |
2,741,191 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 22 '25 |
Sale |
1.00 |
1,355 |
1,358 |
931,714 |
| Egholm Michael | President & CEO |
May 22 '25 |
Sale |
1.00 |
5,116 |
5,126 |
2,746,664 |
| Mackay Sean | SVP & Chief Business Officer |
May 21 '25 |
Sale |
1.03 |
12,838 |
13,223 |
868,829 |
| Mackay Sean | SVP & Chief Business Officer |
May 22 '25 |
Sale |
1.00 |
12,536 |
12,561 |
856,293 |
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):